PFS Partners’s enGene Therapeutics Inc. Common Stock ENGN Stock Holding History

PFS Partners’s Portfolio ENGN Stock Details ENGN Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$74.9K	Hold
2025 Q4	$99.3K	Buy
2025 Q3	$61.5K	Buy